Similar articles

• Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

  Whiteaker JR, Zhang H, Zhao L, Wang P, Kelly-Spratt KS, Ivey RG, Piening BD, Feng LC, Kasarda E, Gurley KE, Eng JK, Chodosh LA, Kemp CJ, McIntosh MW, Paulovich AG. Whiteaker JR, et al. J Proteome Res. 2007 Oct;6(10):3962-75. doi: 10.1021/pr070202v. Epub 2007 Aug 21. J Proteome Res. 2007. PMID: 17711321
• Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.

  Wu DM, Shi J, Liu T, Deng SH, Han R, Xu Y. Wu DM, et al. Cancer Biomark. 2018 Feb 6;21(2):355-365. doi: 10.3233/CBM-170501. Cancer Biomark. 2018. PMID: 29103025
• [Vascular calcification and serum markers].

  Yoshida M, Tomiyama H, Yamashina A. Yoshida M, et al. Clin Calcium. 2010 Nov;20(11):1694-9. Clin Calcium. 2010. PMID: 21037390 Review. Japanese.
• Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.

  Faria M, Halquist MS, Yuan M, Mylott W Jr, Jenkins RG, Karnes HT. Faria M, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:156-68. doi: 10.1016/j.jchromb.2015.05.040. Epub 2015 Jul 26. J Chromatogr B Analyt Technol Biomed Life Sci. 2015. PMID: 26279007
• Proteomic profiling of human plasma for cancer biomarker discovery.

  Huang Z, Ma L, Huang C, Li Q, Nice EC. Huang Z, et al. Proteomics. 2017 Mar;17(6). doi: 10.1002/pmic.201600240. Epub 2016 Oct 17. Proteomics. 2017. PMID: 27550791 Review.